Using AI to accelerate biotech is fast becoming standard practice, and companies offering services to deploy the tech quickly ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Due to rising medication costs, many patients are forced to abandon their treatments. Additionally, the significant lack of ...

Generative AI drug discovery hub Converge Bio raises $5.5M to understand the 'language of biology' - SiliconANGLE ...

The integration of AI with Ayurveda offers promising advancements in personalized healthcare. AI-enhanced diagnostic tools, ...

Discriminative AI, including machine learning and deep learning, is reshaping traditional industries while GenAI is starting ...

In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.

Ramy Farid of Schrödinger maintains that AI drug discovery won't work unless physics-based calculations are part of the ...

Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...

On the heels of U.S. FDA approval for Neurophet Aqua, an updated version of its artificial intelligence (AI)-based magnetic ...

The advancement of Artificial Intelligence (AI) has the potential to transform medical practice by enhancing diagnostic ...

For decades, scientists puzzled over the protein-folding problem of whether a protein’s structure and shape could be ...